Your browser doesn't support javascript.
loading
Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.
Darst, Burcu F; Shen, Jiayi; Madduri, Ravi K; Rodriguez, Alexis A; Xiao, Yukai; Sheng, Xin; Saunders, Edward J; Dadaev, Tokhir; Brook, Mark N; Hoffmann, Thomas J; Muir, Kenneth; Wan, Peggy; Le Marchand, Loic; Wilkens, Lynne; Wang, Ying; Schleutker, Johanna; MacInnis, Robert J; Cybulski, Cezary; Neal, David E; Nordestgaard, Børge G; Nielsen, Sune F; Batra, Jyotsna; Clements, Judith A; Cancer BioResource, Australian Prostate; Grönberg, Henrik; Pashayan, Nora; Travis, Ruth C; Park, Jong Y; Albanes, Demetrius; Weinstein, Stephanie; Mucci, Lorelei A; Hunter, David J; Penney, Kathryn L; Tangen, Catherine M; Hamilton, Robert J; Parent, Marie-Élise; Stanford, Janet L; Koutros, Stella; Wolk, Alicja; Sørensen, Karina D; Blot, William J; Yeboah, Edward D; Mensah, James E; Lu, Yong-Jie; Schaid, Daniel J; Thibodeau, Stephen N; West, Catharine M; Maier, Christiane; Kibel, Adam S; Cancel-Tassin, Géraldine.
Afiliación
  • Darst BF; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA. Electronic address: bdarst@usc.edu.
  • Shen J; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Madduri RK; Argonne National Laboratory, Lemont, IL, USA.
  • Rodriguez AA; Argonne National Laboratory, Lemont, IL, USA.
  • Xiao Y; Argonne National Laboratory, Lemont, IL, USA.
  • Sheng X; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Saunders EJ; The Institute of Cancer Research, London, UK.
  • Dadaev T; The Institute of Cancer Research, London, UK.
  • Brook MN; The Institute of Cancer Research, London, UK.
  • Hoffmann TJ; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Muir K; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Wan P; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Le Marchand L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Wilkens L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Wang Y; Department of Population Science, American Cancer Society, Atlanta, GA, USA.
  • Schleutker J; Institute of Biomedicine, University of Turku, Turku, Finland.
  • MacInnis RJ; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, VIC, Australia.
  • Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Neal DE; Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Headington, Oxford, UK; University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK.
  • Nordestgaard BG; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Nielsen SF; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Batra J; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia; Translational Research Institute, Brisbane, QLD, Australia.
  • Clements JA; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia; Translational Research Institute, Brisbane, QLD, Australia.
  • Cancer BioResource AP; Translational Research Institute, Brisbane, QLD, Australia; Australian Prostate Cancer Research Centre-Qld, Queensland University of Technology, Brisbane, QLD, Australia; Prostate Cancer Research Program, Monash University, Melbourne, VIC, Australia; Dame Roma Mitchell Cancer Centre, University of A
  • Grönberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Pashayan N; University College London, Department of Applied Health Research, London, UK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
  • Travis RC; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Park JY; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
  • Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Weinstein S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Mucci LA; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
  • Hunter DJ; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Penney KL; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA.
  • Tangen CM; SWOG Statistical Center, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Hamilton RJ; Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Surgery (Urology), University of Toronto, Toronto, ON, Canada.
  • Parent MÉ; Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut national de la recherche scientifique, Laval, QC, Canada; Department of Social and Preventive Medicine, School of Public Health, University of Montreal, Montreal, QC, Canada.
  • Stanford JL; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.
  • Koutros S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Wolk A; Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Sørensen KD; Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark.
  • Blot WJ; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; International Epidemiology Institute, Rockville, MD, USA.
  • Yeboah ED; University of Ghana Medical School, Accra, Ghana; Korle Bu Teaching Hospital, Accra, Ghana.
  • Mensah JE; University of Ghana Medical School, Accra, Ghana; Korle Bu Teaching Hospital, Accra, Ghana.
  • Lu YJ; Centre for Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, UK.
  • Schaid DJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Thibodeau SN; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • West CM; Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Radiotherapy Related Research, The Christie Hospital NHS Foundation Trust, Manchester, UK.
  • Maier C; Humangenetik Tuebingen, Tuebingen, Germany.
  • Kibel AS; Division of Urologic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
  • Cancel-Tassin G; CeRePP, Tenon Hospital, Paris, France; Sorbonne Universite, GRC 5 Predictive Onco-urology, Tenon Hospital, Paris, France.
Am J Hum Genet ; 110(7): 1200-1206, 2023 07 06.
Article en En | MEDLINE | ID: mdl-37311464
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Predisposición Genética a la Enfermedad Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Hum Genet Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Predisposición Genética a la Enfermedad Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Hum Genet Año: 2023 Tipo del documento: Article